Tags

Type your tag names separated by a space and hit enter

[Daviditin B from Swertia davidi Franch].
Yao Xue Xue Bao. 2003 Dec; 38(12):931-3.YX

Abstract

AIM

To study the active constituents of Swertia davidi Franch.

METHODS

Chemical components were isolated by column chromatography and their structures were established mainly by spectroscopic means (UV, IR, NMR, 2D-NMR, MS).

RESULTS

Three substances were identified as 2,5-dimethoxyl-1, 4-dicarboxyl benzene (VIII), 1,5,8-trihydroxyl-3,4-dimethoxyl xanthone (IX) and 1,8-dihydroxyl-3-(3'-hydroxyl-butoxy) xanthone (X).

CONCLUSION

Compounds VIII and IX were isolated from Swertia davidi Franch, for the first time, whereas compound X is a new xanthone, named daviditin B with antioxygenated activity in vitro.

Authors+Show Affiliations

Tan GS
School of Pharmaceutical Sciences, Central South University, Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, China. tgs395@yahoo.com.cn
Xu KP
No affiliation info available
Li FS
No affiliation info available
Xu PS
No affiliation info available
Hu GY
No affiliation info available
Jiang DJ
No affiliation info available
Li YJ
No affiliation info available

MeSH

AntioxidantsMolecular ConformationMolecular StructurePlants, MedicinalSwertiaXanthones

Pub Type(s)

English Abstract
Journal Article
Research Support, Non-U.S. Gov't

Language

chi

PubMed ID

15040088

Citation

Tan, Gui-shan, et al. "[Daviditin B From Swertia Davidi Franch]." Yao Xue Xue Bao = Acta Pharmaceutica Sinica, vol. 38, no. 12, 2003, pp. 931-3.
Tan GS, Xu KP, Li FS, et al. [Daviditin B from Swertia davidi Franch]. Yao Xue Xue Bao. 2003;38(12):931-3.
Tan, G. S., Xu, K. P., Li, F. S., Xu, P. S., Hu, G. Y., Jiang, D. J., & Li, Y. J. (2003). [Daviditin B from Swertia davidi Franch]. Yao Xue Xue Bao = Acta Pharmaceutica Sinica, 38(12), 931-3.
Tan GS, et al. [Daviditin B From Swertia Davidi Franch]. Yao Xue Xue Bao. 2003;38(12):931-3. PubMed PMID: 15040088.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Daviditin B from Swertia davidi Franch]. AU - Tan,Gui-shan, AU - Xu,Kang-ping, AU - Li,Fu-shuang, AU - Xu,Ping-sheng, AU - Hu,Gao-yun, AU - Jiang,De-jian, AU - Li,Yuan-jian, PY - 2004/3/26/pubmed PY - 2004/9/15/medline PY - 2004/3/26/entrez SP - 931 EP - 3 JF - Yao xue xue bao = Acta pharmaceutica Sinica JO - Yao Xue Xue Bao VL - 38 IS - 12 N2 - AIM: To study the active constituents of Swertia davidi Franch. METHODS: Chemical components were isolated by column chromatography and their structures were established mainly by spectroscopic means (UV, IR, NMR, 2D-NMR, MS). RESULTS: Three substances were identified as 2,5-dimethoxyl-1, 4-dicarboxyl benzene (VIII), 1,5,8-trihydroxyl-3,4-dimethoxyl xanthone (IX) and 1,8-dihydroxyl-3-(3'-hydroxyl-butoxy) xanthone (X). CONCLUSION: Compounds VIII and IX were isolated from Swertia davidi Franch, for the first time, whereas compound X is a new xanthone, named daviditin B with antioxygenated activity in vitro. SN - 0513-4870 UR - https://www.unboundmedicine.com/medline/citation/15040088/[Daviditin_B_from_Swertia_davidi_Franch]_ DB - PRIME DP - Unbound Medicine ER -